ARROWHEAD PHARMACEUTICALS, INC. Other than Temporary Impairment Losses, Investments
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Other than Temporary Impairment Losses, Investments of $1.64 million for the 131-month period ending 2014-03-31, per its 10-Q filed 2014-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2014-11-25
- ARROWHEAD PHARMACEUTICALS, INC. other than temporary impairment losses, investments for the quarter ending 2012-09-30 was $187.00K.
- ARROWHEAD PHARMACEUTICALS, INC. other than temporary impairment losses, investments for the quarter ending 2012-06-30 was $1.46M.
- ARROWHEAD PHARMACEUTICALS, INC. other than temporary impairment losses, investments for fiscal 2012 was $1.64M.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month | Other than Temporary Impairment Losses, Investments 110 month | Other than Temporary Impairment Losses, Investments 113 month | Other than Temporary Impairment Losses, Investments 116 month | Other than Temporary Impairment Losses, Investments 119 month | Other than Temporary Impairment Losses, Investments 122 month | Other than Temporary Impairment Losses, Investments 125 month | Other than Temporary Impairment Losses, Investments 128 month | Other than Temporary Impairment Losses, Investments 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $1.64M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | $1.64M 10-Q · filed 2014-02-04 | |||||||||||
| 2013-09-30 | $1.64M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | $1.64M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $1.64M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $1.64M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $1.64M derived: sum of 2 quarters · filed 2014-11-25 | $1.64M 10-K · filed 2014-11-25 | $1.64M 10-K · filed 2012-12-28 | ||||||||
| 2012-06-30 | $1.46M 10-Q · filed 2013-08-07 | $1.46M 10-Q · filed 2013-08-07 | $1.46M 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |